Cargando…
S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy
BACKGROUND: An increasing number of patients have been described as having a number of Cystic Fibrosis Transmembrane conductance Regulator (CFTR) variants for which it lacks a clear genotype–phenotype correlation. We assesses the clinical features of patients bearing the S737F (p.Ser737Phe) CFTR mis...
Autores principales: | Terlizzi, Vito, Di Lullo, Antonella Miriam, Comegna, Marika, Centrone, Claudia, Pelo, Elisabetta, Castaldo, Giuseppe, Raia, Valeria, Braggion, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753463/ https://www.ncbi.nlm.nih.gov/pubmed/29298718 http://dx.doi.org/10.1186/s13052-017-0443-z |
Ejemplares similares
-
Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators
por: Terlizzi, Vito, et al.
Publicado: (2023) -
Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers
por: Esposito, Maria Valeria, et al.
Publicado: (2020) -
Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021) -
Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy
por: Taccetti, Giovanni, et al.
Publicado: (2020) -
TAS2R38 is a novel modifier gene in patients with cystic fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)